Chemotherapy Flashcards
D-cycloserine
Structural analogue of D-ala, prevents synthesis of pentapeptide by inhibiting L-Ala racemase, D-Ala-D-Ala synthetase and D-Ala-D-Ala/muramyl tripeptide ligase
Fosfomycin
Inhibits pyruvyl transferase required fro the conversion of NAG to NAM.
Treat UTIs
Bacitracin
Cyclic polypeptide antibiotic. Forms a tight complex with Mg2+ and bactoprenol pyrophosphate, inhibits the dephosphoylation to bactoprenol phosphate (lipid carrier for NAM-NAG unit). Active for gram + bacteria.
Penicillin, Ampicillin, Amoxicillin, Methicillin
Beta-lactam antibiotics. Inhibit peptidoglycan crosslinking transpeptidase enzymes by covalent and irreversible binding as a pseudosubstrate.
Augmentin/Co-amoxiclav
Amoxicillin (beta-lactam antibiotic) and beta-lactamase inhibitor clavulanate combination
Clavulanate
Beta-lactamase inhibitor
forms a slowly hydrolysing acyl-enzyme intermediate
Vancomycin
Glycopeptide antibiotic, binds to D-Ala-D-Ala termini of the pentapeptide in peptidoglycan, so prevents its cross-linking to a neighbouring pentapeptide in another peptidoglycan strand. Effective against C. diff and used IV against gram + cocci such as Enterococcus and Staphylococcus.
Tetracycline
Polyketide antibiotic, binds to 16S rRNA in 30S subunit of ribosome. Inhibits movement of aminoacyl-tRNA into the A site.
Effective against a wide range of bacteria - first line against mycoplasma and cholera (also against plasmodium). Drug toxicity associated with binding of calcium in bones and teeth.
Erythromycin
14-membered macrolide antibiotic. Binds to 23S rRNA in 50S subunit, and blocks the polypeptide exit tunnel. Drug has a similar antibacterial spectrum as penicillin, suitable second line drug for patients allergic to penicillin.
Clindamycin
A lincosamide
Interacts with A and P sites to compete with the binding of loaded tRNA molecules at these positions. Shows activity against certain protozoa including plasmodium too.
Chloramphenicol
Blocks aminoacyl tRNA binding to 50S subunit of ribosome. Very effective broad-spectrum antibiotic, but use is restricted because of bone marrow suppression in some cases. Indicated in life threatening infections such as meningitis.
Fusidic Acid
Inhibits elongation factor G, and hence the movement of the 30S subunit by one codon along the mRNA. Narrow spectrum against staphylococcal infections.
Synercid
Synergistic nonribosomal peptide combination (quinupristin + dalfopristin), blocks polypeptide translocation at 50S subunit of the ribosome by binding to 23S rRNA sites partially overlapping with those targeted by macrolides.
Streptomycin, gentamycin
Aminoglycoside antibiotcs, target 30S subunit near A site, decrease fidelity of mRNA translation. Streptomycin nephrotoxic and ototoxic (ear). These effects are reduced for gentamycin. Used against gram - rods Pseudomonas and Proteus. Most streptococci gram + are resistant as gentamycin can’t penetrate the cell, but penicillin and gentamycin have a synergistic effect against some streptococci.
Ciprofloxacin
Fluoroquinolone antibiotic, inhibits type II DNA topoisomerases (DNA gyrase and topo IV), and hence inhibits changes in supercoiling required for replication and gene expression
Ciprofloxacin is an FDA-approved drug for Bacillus anthracis, also Pseudomonas infections where oral therapy is preferred (e.g. cystic fibrosis respiratory tract infections)
Rifampin
Binds to beta subunit of the DNA-dependent RNA pol, and inhibits initiation of RNA synthesis. Often used to treat Mycobacterium.
Daunorubicin
Binds non-covalently. Planar polycyclic anthracycline antibiotic, intercalates in dsDNA and causes local unwinding. Used as anticancer agent. also topoisomerase II inhibitor.
Bleomycin
Metal-chelating glycopeptide antibiotic, generates superoxide and hydroxyl radicals, causing single and double strand breaks in DNA. Covalently binding
Mitomycin C
Aziridine-containing antibiotic. Alkylates and cross-links at GC. so preventing strand separation during DNA replication and transcription. Covalent binding. Antibiotic and anticancer. G base
Sulfamethoxazole
Sulfa drug. P-aminobenzoate analogue that competitively inhibits DHPS in the biosynthesis of tetrahydrofolate (a methyl carrier required for synthesis of dTMP)
Trimethoprim
Inhibits DHFR in the biosynthesis of tetrahydrofolate
Co-trimoxazole
Combination of sulfamethoxazole and trimethoprim. Co-trimoxazole has been withdrawn as a routine anti-bacterial agent in this country, as result of its being implicated in cases of Stevens-Johnson syndrome (a severe and sometimes fatal allergic reaction). Used in AIDS patients with fungal Pneumocystitis carinii infections.
Valinomycin
Cyclic peptide antibiotic that binds K+ and facilitates K+ diffusion across the membrane
Gramicidin A
Linear polypeptide antibiotic, forms a homodimeric complex that acts as an ion channel in the membrane
Polymixin
Cationic detergent antibiotic containing cyclic peptide and hydrophobic tail, binds to membrane and alters its ion permeability
Amphotericin C
Polyene antifungal and antiparasitic, forms pores in the membrane by an ergosterol-dependent mechanism. Drug of choice for most systemic mycoses: Cryptococcus, candida, aspergillus. Also antiprotozoal
Fluconazole
Triazole antifungal. Inhibit ergosterol biosynthesis. Used in treatment of athlete’s foot and vaginal candidiasis.
Miconazole
Imidazole antifungal and antiprotozoal. Inhibit ergosterol biosynthesis
Melarsen oxide
Arsenic compound. Selectively accumulated in Trypanosoma species. Inhibits metabolism. Treat sleeping sickness
Suramin
Trypanosomiasis drug of choice. Doesn’t contain toxic metal, so therapeutic index much higher than melarsen. Might act on glycolytic enzymes
Chloroquine and mefloquine
Antimalarial 4-aminoquinoline drug - inhibits heme polymerisation in food vacuole of Plasmodium.
Artemisinin
Prodrug of dihydroartemisinin, which is active during the stage where the parasite is inside erythrocytes. MODA might be based on production of oxygen radicals